{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:13:02Z","timestamp":1790957582379,"version":"4.1.0"},"reference-count":94,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00HL122507"],"award-info":[{"award-number":["R00HL122507"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002014"],"award-info":[{"award-number":["UL1TR002014"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Despite decades of research and numerous treatment approaches, hypertension and cardiovascular disease remain leading global public health problems. A major contributor to regulation of blood pressure, and the development of hypertension, is the renin-angiotensin system. Of particular concern, uncontrolled activation of angiotensin II contributes to hypertension and associated cardiovascular risk, with antihypertensive therapies currently available to block the formation and deleterious actions of this hormone. More recently, angiotensin-(1\u20137) has emerged as a biologically active intermediate of the vasodilatory arm of the renin-angiotensin system. This hormone antagonizes angiotensin II actions as well as offers antihypertensive, antihypertrophic, antiatherogenic, antiarrhythmogenic, antifibrotic and antithrombotic properties. Angiotensin-(1\u20137) elicits beneficial cardiovascular actions through mas G protein-coupled receptors, which are found in numerous tissues pivotal to control of blood pressure including the brain, heart, kidneys, and vasculature. Despite accumulating evidence for favorable effects of angiotensin-(1\u20137) in animal models, there is a paucity of clinical studies and pharmacokinetic limitations, thus limiting the development of therapeutic agents to better understand cardiovascular actions of this vasodilatory peptide hormone in humans. This review highlights current knowledge on the role of angiotensin-(1\u20137) in cardiovascular control, with an emphasis on significant animal, human, and therapeutic research efforts.<\/jats:p>","DOI":"10.1093\/ajh\/hpz146","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T11:42:34Z","timestamp":1567683754000},"page":"1133-1142","source":"Crossref","is-referenced-by-count":42,"title":["Angiotensin-(1-7): Translational Avenues in Cardiovascular Control"],"prefix":"10.1093","volume":"32","author":[{"given":"Daniela","family":"Medina","sequence":"first","affiliation":[{"name":"Department of Neural and Behavioral Sciences, Penn State College of Medicine , Hershey, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1380-6017","authenticated-orcid":false,"given":"Amy C","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Neural and Behavioral Sciences, Penn State College of Medicine , Hershey, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"2022101210360815100_CIT0001","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","article-title":"Hypertension and cardiovascular risk: general aspects","volume":"129","author":"Kjeldsen","year":"2018","journal-title":"Pharmacol Res"},{"key":"2022101210360815100_CIT0002","first-page":"1","article-title":"Hypertension prevalence and control among adults: United States, 2015\u20132016","author":"Fryar","year":"2017; 289","journal-title":"NCHS Data Brief"},{"key":"2022101210360815100_CIT0003","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/S0002-9149(01)02321-9","article-title":"The role of the renin-angiotensin system in the development of cardiovascular disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am J Cardiol"},{"key":"2022101210360815100_CIT0004","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","article-title":"The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications","volume":"29","author":"Miller","year":"2019","journal-title":"Clin Auton Res"},{"key":"2022101210360815100_CIT0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the Renin-Angiotensin System: focus on Angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev"},{"key":"2022101210360815100_CIT0006","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev-physiol-012110-142238","article-title":"Renin release: sites, mechanisms, and control","volume":"73","author":"Kurtz","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"2022101210360815100_CIT0007","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"2022101210360815100_CIT0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1470320309347785","article-title":"The angiotensin II type 2 receptor in cardiovascular disease","volume":"11","author":"Lemari\u00e9","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2022101210360815100_CIT0009","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/HYPERTENSIONAHA.116.08814","article-title":"Evidence for heterodimerization and functional interaction of the angiotensin type 2 receptor and the receptor MAS","volume":"69","author":"Leonhardt","year":"2017","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2018.06.007","article-title":"Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor","volume":"50","author":"Gaidarov","year":"2018","journal-title":"Cell Signal"},{"key":"2022101210360815100_CIT0011","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/CS20120461","article-title":"Angiotensin-(1-7): beyond the cardio-renal actions","volume":"124","author":"Passos-Silva","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"2022101210360815100_CIT0012","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1590\/S0100-879X2000000600012","article-title":"Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart","volume":"33","author":"Almeida","year":"2000","journal-title":"Braz J Med Biol Res"},{"key":"2022101210360815100_CIT0013","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.HYP.37.2.703","article-title":"Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo","volume":"37","author":"Fernandes","year":"2001","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0014","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.HYP.27.3.523","article-title":"Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide","volume":"27","author":"Brosnihan","year":"1996","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways","volume":"49","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0016","doi-asserted-by":"crossref","first-page":"H1985","DOI":"10.1152\/ajpheart.01145.2002","article-title":"Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats","volume":"284","author":"Sampaio","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022101210360815100_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2019.03.007","article-title":"Angiotensin-(1-7) induced vascular relaxation in spontaneously hypertensive rats","volume":"88","author":"Zhang","year":"2019","journal-title":"Nitric Oxide"},{"key":"2022101210360815100_CIT0018","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/HJH.0b013e32835ecbe5","article-title":"Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity","volume":"31","author":"Beyer","year":"2013","journal-title":"J Hypertens"},{"key":"2022101210360815100_CIT0019","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1753944712461164","article-title":"Altered regional blood flow distribution in Mas-deficient mice","volume":"6","author":"Botelho-Santos","year":"2012","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2022101210360815100_CIT0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2119\/2007-00073.Fraga-Silva","article-title":"The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets","volume":"14","author":"Fraga-Silva","year":"2008","journal-title":"Mol Med"},{"key":"2022101210360815100_CIT0021","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/jcbfm.2015.30","article-title":"Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice","volume":"35","author":"Shimada","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"2022101210360815100_CIT0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2018.11.045","article-title":"Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice","author":"Stegbauer","year":"2019","journal-title":"J Vasc Surg"},{"key":"2022101210360815100_CIT0023","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3892\/mmr.2017.6848","article-title":"The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction","volume":"16","author":"Wang","year":"2017","journal-title":"Mol Med Rep"},{"key":"2022101210360815100_CIT0024","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/fcp.12318","article-title":"Angiotensin-converting enzyme 2-Angiotensin 1-7\/1-9 system: novel promising targets for heart failure treatment","volume":"32","author":"Kittana","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"2022101210360815100_CIT0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00380-009-1213-7","article-title":"The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-beta1\/Smad2 expression","volume":"25","author":"He","year":"2010","journal-title":"Heart Vessels"},{"key":"2022101210360815100_CIT0026","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.lfs.2006.09.007","article-title":"Effects of genetic deletion of angiotensin-(1-7) receptor Mas on cardiac function during ischemia\/reperfusion in the isolated perfused mouse heart","volume":"80","author":"Castro","year":"2006","journal-title":"Life Sci"},{"key":"2022101210360815100_CIT0027","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2174\/0929866524666170728154459","article-title":"Vasodilator effect of angiotensin-(1-7) on vascular coronary bed of rats: role of Mas, ACE and ACE2","volume":"24","author":"de Moraes","year":"2017","journal-title":"Protein Pept Lett"},{"key":"2022101210360815100_CIT0028","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/CS20120519","article-title":"Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts","volume":"125","author":"Souza","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"2022101210360815100_CIT0029","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1369\/0022155411411712","article-title":"The angiotensin-(1-7)\/Mas receptor axis is expressed in sinoatrial node cells of rats","volume":"59","author":"Ferreira","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"2022101210360815100_CIT0030","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1113\/EP085884","article-title":"New insights into the elucidation of angiotensin-(1-7) in vivo antiarrhythmic effects and its related cellular mechanisms","volume":"101","author":"Joviano-Santos","year":"2016","journal-title":"Exp Physiol"},{"key":"2022101210360815100_CIT0031","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1590\/S0100-879X1997000600016","article-title":"Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts","volume":"30","author":"Neves","year":"1997","journal-title":"Braz J Med Biol Res"},{"key":"2022101210360815100_CIT0032","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0895-7061(97)00400-7","article-title":"Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects","volume":"11","author":"Ferrario","year":"1998","journal-title":"Am J Hypertens"},{"key":"2022101210360815100_CIT0033","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/hy0302.104673","article-title":"Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles","volume":"39","author":"Ren","year":"2002","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0034","doi-asserted-by":"crossref","first-page":"H666","DOI":"10.1152\/ajpheart.00372.2006","article-title":"Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction","volume":"292","author":"Benter","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022101210360815100_CIT0035","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/HJH.0000000000000917","article-title":"Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia","volume":"34","author":"van Twist","year":"2016","journal-title":"J Hypertens"},{"key":"2022101210360815100_CIT0036","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1097\/HJH.0000000000000351","article-title":"Angiotensin-(1-7)-induced renal vasodilation is reduced in human kidneys with renal artery stenosis","volume":"32","author":"Van Twist","year":"2014","journal-title":"J Hypertens"},{"key":"2022101210360815100_CIT0037","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/HYPERTENSIONAHA.113.01814","article-title":"Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion","volume":"62","author":"van Twist","year":"2013","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0038","doi-asserted-by":"crossref","first-page":"e14015","DOI":"10.14814\/phy2.14015","article-title":"Angiotensin-(1-7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb","volume":"7","author":"Dibo","year":"2019","journal-title":"Physiol Rep"},{"key":"2022101210360815100_CIT0039","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/0929866526666190405123422","article-title":"Beneficial effects of the angiotensin-converting enzyme 2 activator dize in renovascular hypertension","volume":"26","author":"Kangussu","year":"2019","journal-title":"Protein Pept Lett"},{"key":"2022101210360815100_CIT0040","doi-asserted-by":"crossref","first-page":"F812","DOI":"10.1152\/ajprenal.00655.2013","article-title":"Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity","volume":"306","author":"Mori","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022101210360815100_CIT0041","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ki.2009.61","article-title":"Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria","volume":"75","author":"Pinheiro","year":"2009","journal-title":"Kidney Int"},{"key":"2022101210360815100_CIT0042","doi-asserted-by":"crossref","first-page":"H1416","DOI":"10.1152\/ajpheart.00141.2007","article-title":"Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain","volume":"293","author":"Becker","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022101210360815100_CIT0043","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0361-9230(99)00237-3","article-title":"Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata","volume":"51","author":"Averill","year":"2000","journal-title":"Brain Res Bull"},{"key":"2022101210360815100_CIT0044","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cvr\/cvq059","article-title":"Astroglia are a possible cellular substrate of angiotensin(1-7) effects in the rostral ventrolateral medulla","volume":"87","author":"Guo","year":"2010","journal-title":"Cardiovasc Res"},{"key":"2022101210360815100_CIT0045","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1042\/CS20180236","article-title":"Angiotensin generation in the brain: a re-evaluation","volume":"132","author":"Uijl","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"2022101210360815100_CIT0046","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FJC.0b013e3182588b32","article-title":"In vivo expression of angiotensin-(1-7) lowers blood pressure and improves baroreflex function in transgenic (mRen2)27 rats","volume":"60","author":"Garcia-Espinosa","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"2022101210360815100_CIT0047","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/HYPERTENSIONAHA.113.01847","article-title":"Increasing angiotensin-(1-7) levels in the brain attenuates metabolic syndrome-related risks in fructose-fed rats","volume":"63","author":"Guimaraes","year":"2014","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0048","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.coph.2011.02.001","article-title":"Angiotensin peptides and central autonomic regulation","volume":"11","author":"Diz","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"2022101210360815100_CIT0049","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.HYP.0000259942.38108.20","article-title":"Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats","volume":"49","author":"Yamazato","year":"2007","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0050","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/01.HYP.0000143850.73831.9d","article-title":"Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats","volume":"44","author":"Gironacci","year":"2004","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0051","doi-asserted-by":"crossref","first-page":"H1458","DOI":"10.1152\/ajpheart.00497.2018","article-title":"Central ANG-(1-7) infusion improves blood pressure regulation in antenatal betamethasone-exposed sheep and reveals sex-dependent effects on oxidative stress","volume":"316","author":"Hendricks","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022101210360815100_CIT0052","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/HYPERTENSIONAHA.107.106005","article-title":"Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen","volume":"51","author":"Arnold","year":"2008","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0053","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.HYP.37.5.1309","article-title":"Baroreflex improvement in shr after ace inhibition involves angiotensin-(1-7)","volume":"37","author":"Heringer-Walther","year":"2001","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0054","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.peptides.2010.06.030","article-title":"Altered cardiovascular reflexes responses in conscious Angiotensin-(1-7) receptor Mas-knockout mice","volume":"31","author":"de Moura","year":"2010","journal-title":"Peptides"},{"key":"2022101210360815100_CIT0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10557-014-6555-4","article-title":"Angiotensin-(1-7) modulates angiotensin II-induced vasoconstriction in human mammary artery","volume":"28","author":"Mendon\u00e7a","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"key":"2022101210360815100_CIT0056","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.peptides.2018.08.008","article-title":"Effects of angiotensin-(1-7) and angiotensin II on vascular tone in human cirrhotic splanchnic vessels","volume":"108","author":"Casey","year":"2018","journal-title":"Peptides"},{"key":"2022101210360815100_CIT0057","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.HYP.34.2.296","article-title":"Angiotensin-(1-7) is a modulator of the human renin-angiotensin system","volume":"34","author":"Roks","year":"1999","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0058","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/ATVBAHA.116.307518","article-title":"Vascular actions of angiotensin 1-7 in the human microcirculation: novel role for telomerase","volume":"36","author":"Durand","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022101210360815100_CIT0059","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.HYP.34.3.457","article-title":"Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor","volume":"34","author":"Davie","year":"1999","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0060","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.HYP.37.4.1136","article-title":"Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm","volume":"37","author":"Wilsdorf","year":"2001","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0061","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/01.HYP.38.1.90","article-title":"Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension","volume":"38","author":"Sasaki","year":"2001","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0062","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/00004872-200111000-00010","article-title":"Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man","volume":"19","author":"Ueda","year":"2001","journal-title":"J Hypertens"},{"key":"2022101210360815100_CIT0063","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/01.HYP.35.4.998","article-title":"Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man","volume":"35","author":"Ueda","year":"2000","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0064","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.117.10280","article-title":"Favorable vascular actions of angiotensin-(1-7) in human obesity","volume":"71","author":"Schinzari","year":"2018","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0065","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/0024-3205(86)90565-5","article-title":"Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man","volume":"38","author":"Kono","year":"1986","journal-title":"Life Sci"},{"key":"2022101210360815100_CIT0066","doi-asserted-by":"crossref","first-page":"R981","DOI":"10.1152\/ajpregu.00263.2003","article-title":"Effects of truncated angiotensins in humans after double blockade of the renin system","volume":"285","author":"Plovsing","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2022101210360815100_CIT0067","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1527-3466.2007.00012.x","article-title":"Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments","volume":"25","author":"Trask","year":"2007","journal-title":"Cardiovasc Drug Rev"},{"key":"2022101210360815100_CIT0068","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1527-3466.2006.00239.x","article-title":"Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist","volume":"24","author":"Santos","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"2022101210360815100_CIT0069","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.HYP.0000037979.53963.8F","article-title":"AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium","volume":"40","author":"Wiemer","year":"2002","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0070","doi-asserted-by":"crossref","first-page":"e0138732","DOI":"10.1371\/journal.pone.0138732","article-title":"Hemodynamic effects of the non-peptidic angiotensin-(1-7) agonist AVE0991 in liver cirrhosis","volume":"10","author":"Klein","year":"2015","journal-title":"PLoS One"},{"key":"2022101210360815100_CIT0071","doi-asserted-by":"crossref","first-page":"H1113","DOI":"10.1152\/ajpheart.00828.2006","article-title":"The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction","volume":"292","author":"Ferreira","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022101210360815100_CIT0072","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1111\/bph.13685","article-title":"Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis","volume":"174","author":"Skiba","year":"2017","journal-title":"Br J Pharmacol"},{"key":"2022101210360815100_CIT0073","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/HYPERTENSIONAHA.110.152942","article-title":"Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor","volume":"56","author":"Savergnini","year":"2010","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0074","doi-asserted-by":"crossref","first-page":"e57757","DOI":"10.1371\/journal.pone.0057757","article-title":"The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats","volume":"8","author":"Savergnini","year":"2013","journal-title":"PLoS One"},{"key":"2022101210360815100_CIT0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.peptides.2013.11.006","article-title":"An orally active angiotensin-(1-7) inclusion compound and exercise training produce similar cardiovascular effects in spontaneously hypertensive rats","volume":"51","author":"Bertagnolli","year":"2014","journal-title":"Peptides"},{"key":"2022101210360815100_CIT0076","doi-asserted-by":"crossref","first-page":"795452","DOI":"10.1155\/2012\/795452","article-title":"Beneficial effects of long-term administration of an oral formulation of Angiotensin-(1-7) in infarcted rats","volume":"2012","author":"Marques","year":"2012","journal-title":"Int J Hypertens"},{"key":"2022101210360815100_CIT0077","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1160\/TH13-06-0448","article-title":"Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques","volume":"111","author":"Fraga-Silva","year":"2014","journal-title":"Thromb Haemost"},{"key":"2022101210360815100_CIT0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2019.103486","article-title":"Angiotensin-(1-7) oral treatment after experimental myocardial infarction leads to downregulation of CXCR4","author":"G\u00f3mez-Mendoza","year":"2019","journal-title":"J Proteomics"},{"key":"2022101210360815100_CIT0079","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.108.146431","article-title":"Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog","volume":"328","author":"Kluskens","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"2022101210360815100_CIT0080","doi-asserted-by":"crossref","first-page":"536426","DOI":"10.1155\/2012\/536426","article-title":"The effect of the thioether-bridged, stabilized Angiotensin-(1-7) analogue cyclic ang-(1-7) on cardiac remodeling and endothelial function in rats with myocardial infarction","volume":"2012","author":"Durik","year":"2012","journal-title":"Int J Hypertens"},{"key":"2022101210360815100_CIT0081","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1113\/expphysiol.2009.047407","article-title":"Angiotensin-converting enzyme 2: a new target for neurogenic hypertension","volume":"95","author":"Feng","year":"2010","journal-title":"Exp Physiol"},{"key":"2022101210360815100_CIT0082","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.HYP.30.3.535","article-title":"Counterregulatory actions of angiotensin-(1-7)","volume":"30","author":"Ferrario","year":"1997","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0083","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/HYPERTENSIONAHA.108.114322","article-title":"Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function","volume":"52","author":"Rentzsch","year":"2008","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0084","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.107.108944","article-title":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents","volume":"51","author":"Hern\u00e1ndez Prada","year":"2008","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2119\/molmed.2009.00160","article-title":"ACE2 activation promotes antithrombotic activity","volume":"16","author":"Fraga-Silva","year":"2010","journal-title":"Mol Med"},{"key":"2022101210360815100_CIT0086","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.regpep.2012.05.093","article-title":"Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction","volume":"177","author":"Mur\u00e7a","year":"2012","journal-title":"Regul Pept"},{"key":"2022101210360815100_CIT0087","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.200811-1678OC","article-title":"Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension","volume":"179","author":"Ferreira","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2022101210360815100_CIT0088","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.biopha.2018.07.170","article-title":"The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats","volume":"107","author":"Castardeli","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"2022101210360815100_CIT0089","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1139\/cjpp-2019-0078","article-title":"Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?","volume":"97","author":"Badae","year":"2019","journal-title":"Can J Physiol Pharmacol"},{"key":"2022101210360815100_CIT0090","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00424-016-1875-9","article-title":"Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating KCa3.1 channel via ERK1\/2 pathway","volume":"468","author":"Wang","year":"2016","journal-title":"Pflugers Arch"},{"key":"2022101210360815100_CIT0091","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/HYPERTENSIONAHA.112.198622","article-title":"Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2","volume":"60","author":"Ye","year":"2012","journal-title":"Hypertension"},{"key":"2022101210360815100_CIT0092","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"2022101210360815100_CIT0093","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02638-2017","article-title":"A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension","volume":"51","author":"Hemnes","year":"2018","journal-title":"Eur Respir J"},{"key":"2022101210360815100_CIT0094","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit Care"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpz146\/30131004\/hpz146.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/32\/12\/1133\/46454888\/ajh_32_12_1133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/32\/12\/1133\/46454888\/ajh_32_12_1133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T11:21:27Z","timestamp":1665573687000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/32\/12\/1133\/5564095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":94,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,9,6]]},"published-print":{"date-parts":[[2019,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpz146","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,9,6]]}}}